Data on Immunogen’s breast cancer drug shows promise in more patients

New data on a drug developed by Immunogen Inc. (Nasdaq: IMGN) to treat an aggressive form of breast cancer shows it can stave off the spread of cancer longer than other drugs on the market, potentially paving the way for it to be used in more patients...